Demonstrating significant benefit of orphan medicines: analysis of 15 years of experience in Europe

Ano

2018

Tipo de Documento

Artigos

Departamentos

Departamento de Ciências Farmacológicas

Referência

Fregonese L, Greene L, Hofer M, Magrelli A, Naumann-Winter F, Larsson K, Sheeanl M, Stoyanova-Beninska V, Tsigkosl S, Westermark K, Sepodes B.. Demonstrating significant benefit of orphan medicines: analysis of 15 years of experience in Europe. Drug Discovery Today. 2018. 23. 1. 90-100